Please use this identifier to cite or link to this item: http://dspace.lamu.edu.zm:8080/handle/123456789/2908
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGill, J. Christopher-
dc.contributor.authorMwananyanda, Lawrence-
dc.contributor.authorKwenda, Geoffrey-
dc.contributor.authorMagdalene, Mwale-
dc.contributor.authorWilliams, L. Anna-
dc.contributor.authorSiazeele, Kazunga-
dc.contributor.authorZhaoyan, Yang-
dc.contributor.authorMwansa, James-
dc.contributor.authorThea, M. Donald-
dc.date.accessioned2023-07-26T08:17:15Z-
dc.date.available2023-07-26T08:17:15Z-
dc.date.issued2016-
dc.identifier.urihttp://155.0.177.102:8080/jspui//xmlui/handle/123456789/2908-
dc.descriptionThis article can also be accessed on DOI: 10.1093/cid/ciw526en_US
dc.description.abstractBackground. Maternal vaccination with tetanus, reduced-dose diphtheria, and acellular pertussis vaccine (Tdap) could be an effective way of mitigating the high residual burden of infant morbidity and mortality caused by Bordetella pertussis. To better inform such interventions, we conducted a burden-of-disease study to determine the incidence of severe and nonsevere pertussis among a population of Zambian infants. Methods. Mother–infant pairs were enrolled at 1 week of life, and then seen at 2- to 3-week intervals through 14 weeks of age. At each visit, nasopharyngeal (NP) swabs were obtained from both, and symptoms were catalogued. Using polymerase chain reaction (PCR) to identify cases, and a severity scoring system to triage these into severe/nonsevere, we calculated disease incidence using person-time at risk as the denominator. Results. From a population of 1981 infants, we identified 10 with clinical pertussis, for an overall incidence of 2.4 cases (95% confidence interval [CI], 1.2–4.2) per 1000 infant-months and a cumulative incidence of 5.2 cases (95% CI, 2.6–9.0) per 1000 infants. Nine of 10 cases occurred within a 3-month window (May–July 2015), with highest incidence between birth and 6 weeks of age (3.5 cases per 1000 infant-months), concentrated among infants prior to vaccination or among those who had only received 1 dose of Diphtheria Tetanus whole cell Pertussis (DTwP). Maternal human immunodeficiency virus (HIV) modestly increased the risk of infant pertussis (risk ratio, 1.8 [95% CI, .5–6.9]). Only 1 of 10 infant cases qualified as having severe pertussis. The rest presented with the mild and nonspecific symptoms of cough, coryza, and/or tachypnea. Notably, cough durations were long, exceeding 30 days in several cases, with PCRs repeatedly positive over time. Conclusions. Pertussis is circulating freely among this population of Zambian infants but rarely presents with the classical symptoms of paroxysmal cough, whooping, apnea, and cyanosis. Maternal HIV appears to increase the risk, while lack of effective exposure to DTwP increased the risk.en_US
dc.language.isoenen_US
dc.publisherOxford University Press for the Infectious Diseases Society of Americaen_US
dc.relation.ispartofseriesClinical Infectious Diseases;Vol.63(S4)-
dc.subjectWhooping Coughen_US
dc.subjectBordetella Pertussisen_US
dc.subjectIncidenceen_US
dc.subjectCohort Studyen_US
dc.subjectPerspective Surveillanceen_US
dc.titleIncidence of Severe and Non severe Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Studyen_US
dc.typeArticleen_US
Appears in Collections:Pediatrics

Files in This Item:
File Description SizeFormat 
ciw526.pdf425.19 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.